CClinicalTrials.gg
CompletedNCT04191720Updated Dec 10, 2019

Assessing the Impact of Weighted Blankets on Anxiety Among Inpatients With Anorexia Nervosa: a Study Protocol

An interventional study of Weighted blanket in Anorexia Nervosa, Avoidant/Restrictive Food Intake Disorder and Anxiety, sponsored by Denver Health and Hospital Authority. Completed at 1 site in United States. Open to participants aged 18 Years to 89 Years. Per ClinicalTrials.gov, last updated 2019-12-10.

Sponsored by Denver Health and Hospital Authority · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 1 year after the study started (first participant enrolled Nov 2018, registered Dec 2019).
Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
18 Years to 89 Years
Sex
All
01

Study summary

The aim of this study is to conduct a randomized control trial (RCT) to assess the efficacy of weighted blankets (WB), on anxiety for patients with severe anorexia nervosa (AN) and avoidant restrictive food intake disorder (ARFID) in an inpatient medical setting. We hypothesize that using weighted blankets will reduce anxiety in these patient populations.

Read the detailed description

Anorexia nervosa (AN) has one of the highest mortality rates of any psychiatric disorder with anxiety being a common comorbidity. The standard of care for inpatient medical stabilization for patients diagnosed with AN is a multidisciplinary approach with emphasis on nutrition, psychotherapy, and medical management of complaints. Weighted blankets, an example of deep pressure stimulation, have been shown to reduce anxiety. However, not much is known about the effect of weighted blankets in the eating disorder population. Therefore, this randomized control trial (RCT) protocol outlines a study design for assessing the effect of weighted blankets on patients with AN.

A two-arm RCT design will be implemented for this study. A convenience sample of 24 patients will be enrolled with 12 patients in the control and intervention groups based on inclusion criteria. The control group will receive Denver Health's standard of care for patients admitted to its well-known medical stabilization unit for patients with extreme form of eating disorders, while the intervention group will receive both the standard of care and a weighted blanket. A mixed-design ANOVA will be performed to explore differences in the Beck's Anxiety Inventory and Subjective Units of Distress Scale between the intervention and control groups.

02

Conditions studied

  • Anorexia Nervosa
  • Avoidant/Restrictive Food Intake Disorder
  • Anxiety

Keywords

  • anorexia nervosa
  • weighted blankets
  • occupational therapy
  • anxiety
  • deep pressure stimulation
  • randomized control trial
03

In context

Anorexia

411 studies on the registry are indexed under Anorexia; 67 are open to participants now.

This study's enrollment of 24 is below the median of 41 across 287 interventional studies indexed under Anorexia.

Browse Anorexia studies →

Lead sponsor

Denver Health and Hospital Authority is the lead sponsor of 84 studies on the registry; 4 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 8 (89%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 89 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Clinically diagnosed with AN-R, AN-BP, or ARFID upon admission (per Diagnostic and Statistical Manual-V criteria)
  • Moderate/Major Anxiety per initial evaluation score using BAI
  • OT assessment

Exclusion criteria

Exclusion Criteria:

  • Pregnant or nursing mothers
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
24 participants (actual)

Study arms

  • No intervention
    Control group

    The control group, or usual care group, will receive occupational therapy standard of care. Occupational therapy standard of care provide training, education, and therapeutic activities including relaxation strategies. These coping mechanisms are aimed at reducing the impact of anxiety on a patient's performance and participation in necessary and meaningful activities of daily living, refeeding and medical stabilization. Specifically, these interventions will include diaphragmatic and yogic breathing exercises, mindfulness-based cognitive therapy (MBCT) education and exercises, therapeutic restorative yoga activities, occupational therapy group participation, aromatherapy, identifying and promoting engagement in meaningful leisure activities, client-centered sensory diets to provide patients with consistent preferred sensory experiences, and individualized checklists and schedules to grade the self-initiation of effective coping strategies.

  • Experimental
    Weighted blanket group

    In the weighted blanket intervention group, patients will receive usual occupational therapy care in addition to a weighted blanket. The patient will be given an appropriately weighted blanket, within 1 lb +/- of 10% of body weight as measured on day of admission. Further, the occupational therapy will provide education to the patient on the use of the weighted blanket. Patients will be free to use the weighted blanket at their discretion, however, during meals, over the shoulders or head, and during ambulation, weighted blanket use will not be permitted.

    Other: Weighted blanket

Interventions

  • OtherWeighted blanket

    Patients that were randomly assigned to the intervention group received a weighted blanket to use at their will to reduce anxiety

06

What researchers measure

Primary outcomes

  1. Anxiety reduction

    Beck Anxiety Inventory (BAI)

    Time frame: BAI measured during OT evaluation and through study completion, an average of 1 year

  2. Anxiety reduction

    Subjective Units of Distress Scale (SUDS)

    Time frame: SUDS are measured during OT evaluation and through study completion, an average of 3 weeks

Secondary outcomes

  1. Times weighted blankets are used

    Ratio of times weighted blankets were used vs when not in use

    Time frame: Behaviors will be documented every 2 hours over the course of treatment, through study completion, an average of 3 weeks

07

Study locations

1 site
  • Denver Health and Hospital Authority
    Denver, Colorado 80204, United States
08

References and documents

Publications

  • Hoek HW. Incidence, prevalence and mortality of anorexia nervosa and other eating disorders. Curr Opin Psychiatry. 2006 Jul;19(4):389-94. doi: 10.1097/01.yco.0000228759.95237.78. PubMed 16721169 ↗
  • Hudson JI, Hiripi E, Pope HG Jr, Kessler RC. The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry. 2007 Feb 1;61(3):348-58. doi: 10.1016/j.biopsych.2006.03.040. Epub 2006 Jul 3. Erratum In: Biol Psychiatry. 2012 Jul 15;72(2):164. PubMed 16815322 ↗
  • Khalsa SS, Portnoff LC, McCurdy-McKinnon D, Feusner JD. What happens after treatment? A systematic review of relapse, remission, and recovery in anorexia nervosa. J Eat Disord. 2017 Jun 14;5:20. doi: 10.1186/s40337-017-0145-3. eCollection 2017. PubMed 28630708 ↗
  • Paslakis G, Maas S, Gebhardt B, Mayr A, Rauh M, Erim Y. Prospective, randomized, double-blind, placebo-controlled phase IIa clinical trial on the effects of an estrogen-progestin combination as add-on to inpatient psychotherapy in adult female patients suffering from anorexia nervosa. BMC Psychiatry. 2018 Apr 10;18(1):93. doi: 10.1186/s12888-018-1683-1. PubMed 29631553 ↗
  • Nakai Y, Nin K, Noma S, Teramukai S, Wonderlich SA. Characteristics of Avoidant/Restrictive Food Intake Disorder in a Cohort of Adult Patients. Eur Eat Disord Rev. 2016 Nov;24(6):528-530. doi: 10.1002/erv.2476. Epub 2016 Sep 4. PubMed 27594387 ↗
  • Elliot ML. Figured world of eating disorders: occupations of illness. Can J Occup Ther. 2012 Feb;79(1):15-22. doi: 10.2182/cjot.2012.79.1.3. PubMed 22439288 ↗
  • Chakraborty K, Basu D. Management of anorexia and bulimia nervosa: An evidence-based review. Indian J Psychiatry. 2010 Apr;52(2):174-86. doi: 10.4103/0019-5545.64596. PubMed 20838508 ↗
  • Sebastian MR, Wiemann CM, Hergenroeder AC. Rate of weight gain as a predictor of readmission in adolescents with eating disorders. Int J Adolesc Med Health. 2019 Feb 26;33(4). doi: 10.1515/ijamh-2018-0228. PubMed 30807289 ↗
  • Altman SE, Shankman SA. What is the association between obsessive-compulsive disorder and eating disorders? Clin Psychol Rev. 2009 Nov;29(7):638-46. doi: 10.1016/j.cpr.2009.08.001. Epub 2009 Aug 16. PubMed 19744759 ↗
  • Nicely TA, Lane-Loney S, Masciulli E, Hollenbeak CS, Ornstein RM. Prevalence and characteristics of avoidant/restrictive food intake disorder in a cohort of young patients in day treatment for eating disorders. J Eat Disord. 2014 Aug 2;2(1):21. doi: 10.1186/s40337-014-0021-3. eCollection 2014. PubMed 25165558 ↗
  • Meier SM, Bulik CM, Thornton LM, Mattheisen M, Mortensen PB, Petersen L. Diagnosed Anxiety Disorders and the Risk of Subsequent Anorexia Nervosa: A Danish Population Register Study. Eur Eat Disord Rev. 2015 Nov;23(6):524-30. doi: 10.1002/erv.2402. Epub 2015 Sep 8. PubMed 26347124 ↗
  • Chen H-Y, Yang H, Chi H-J. Physiological Effects of Deep Touch Pressure on Anxiety Alleviation: The Weighted Blanket Approach. Journal of Medical and Biological Engineering. 2013;33(5):463-70.
  • Edelson SM, Edelson MG, Kerr DC, Grandin T. Behavioral and physiological effects of deep pressure on children with autism: a pilot study evaluating the efficacy of Grandin's Hug Machine. Am J Occup Ther. 1999 Mar-Apr;53(2):145-52. doi: 10.5014/ajot.53.2.145. PubMed 10200837 ↗
  • Grandin T. Calming effects of deep touch pressure in patients with autistic disorder, college students, and animals. J Child Adolesc Psychopharmacol. 1992 Spring;2(1):63-72. doi: 10.1089/cap.1992.2.63. PubMed 19630623 ↗
  • Krauss KE. The effects of deep pressure touch on anxiety. Am J Occup Ther. 1987 Jun;41(6):366-73. doi: 10.5014/ajot.41.6.366. PubMed 3688151 ↗
  • Reynolds S, Lane SJ, Mullen B. Effects of deep pressure stimulation on physiological arousal. Am J Occup Ther. 2015 May-Jun;69(3):6903350010p1-5. doi: 10.5014/ajot.2015.015560. PubMed 25871605 ↗
  • Kimball JG, Lynch KM, Stewart KC, Williams NE, Thomas MA, Atwood KD. Using salivary cortisol to measure the effects of a Wilbarger protocol-based procedure on sympathetic arousal: a pilot study. Am J Occup Ther. 2007 Jul-Aug;61(4):406-13. doi: 10.5014/ajot.61.4.406. PubMed 17685173 ↗
  • Sylvia LG, Shesler LW, Peckham AD, Grandin T, Kahn DA. Adjunctive deep touch pressure for comorbid anxiety in bipolar disorder: mediated by control of sensory input? J Psychiatr Pract. 2014 Jan;20(1):71-7. doi: 10.1097/01.pra.0000442942.01479.ce. PubMed 24419314 ↗
  • VandenBerg NL. The use of a weighted vest to increase on-task behavior in children with attention difficulties. Am J Occup Ther. 2001 Nov-Dec;55(6):621-8. doi: 10.5014/ajot.55.6.621. PubMed 12959226 ↗
  • Champagne T, Stromberg N. Sensory approaches in inpatient psychiatric settings: innovative alternatives to seclusion & restraint. J Psychosoc Nurs Ment Health Serv. 2004 Sep;42(9):34-44. doi: 10.3928/02793695-20040901-06. PubMed 15493494 ↗
  • Chen HY, Yang H, Meng LF, Chan PS, Yang CY, Chen HM. Effect of deep pressure input on parasympathetic system in patients with wisdom tooth surgery. J Formos Med Assoc. 2016 Oct;115(10):853-859. doi: 10.1016/j.jfma.2016.07.008. Epub 2016 Aug 24. PubMed 27568389 ↗
  • Tanner BA. Validity of global physical and emotional SUDS. Appl Psychophysiol Biofeedback. 2012 Mar;37(1):31-4. doi: 10.1007/s10484-011-9174-x. PubMed 22038278 ↗

Individual participant data

Plan to share: No — If we decide to share the data, we would ask researchers to reach out to the PI

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 10, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04191720
Lead sponsor
Denver Health and Hospital Authority
Responsible party
Rachel Ohene (Occupational Therapist, Denver Health and Hospital Authority) — Principal investigator
First posted
Dec 10, 2019
Start date
Nov 16, 2018
Primary completion
Mar 19, 2019
Completion
Nov 30, 2019
Last update
Dec 10, 2019

Study contacts

Rachel Ohene, MOT
principal investigator · Denver Health Hospital and Authority

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion